Moderna

The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.

Moderna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its Covid booster shot.

The Biden administration says it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine targeting the highly transmissible omicron variant.

The federal government is expected to authorize COVID-19 vaccinations for kids as young as 6 months old this weekend, with the CDC go-ahead vote Saturday the last hurdle to clear before doses can start being administered to babies across the U.S. The final decision will rest with CDC Director Dr. Rochelle Walensky, but she is expected to align with her…

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17. A vaccine made by Pfizer has been available since last year for those ages. The Food and Drug...

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.

The latest expansion comes as omicron subvariant BA.2 fuels fresh worries over the COVID pandemic; cases are rising but hospitalizations and deaths are still down and experts don’t expect a huge surge New York state outlined its second COVID booster eligibility guidance on Saturday, days after the five boroughs started offering the fourth vaccine doses following the federal government’s...

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

New York City-run COVID sites are officially offering second booster shots for eligible people starting Thursday, a day after initially turning some away as health officials ironed out the guidelines. Retail pharmacies are also on board. The CDC endorsed the FDA’s authorization of the fourth shot for Pfizer and Moderna recipients age 50 and older who are at least four…

The CDC and FDA have recommended a second booster dose of the Pfizer and Moderna vaccines for people age 50 and older. But why did the recommendation come out so quickly? And will we have to get a yearly booster shot in the future? Dr. Uché Blackstock shares her thoughts.

New York City will start offering a second booster shot Thursday for people over 50 years old and older. Adam Kuperstein reports.

The latest booster recommendation is getting mixed reaction, even from those who have already gotten all of their shots. NBC New York’s Ida Siegal reports.

Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers

The request comes two days after Pfizer asked the Food and Drug Administration to authorize a second booster shot for adults 65 and older.